Daiwa Securities Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,450
Closed -$597K 1083
2016
Q4
$597K Buy
7,450
+600
+9% +$47.6K ﹤0.01% 505
2016
Q3
$546K Hold
6,850
﹤0.01% 489
2016
Q2
$534K Buy
6,850
+250
+4% +$17.8K ﹤0.01% 484
2016
Q1
$363K Buy
6,600
+300
+5% +$16.3K ﹤0.01% 551
2015
Q4
$389K Sell
6,300
-300
-5% -$18.9K ﹤0.01% 530
2015
Q3
$416K Hold
6,600
﹤0.01% 518
2015
Q2
$482K Hold
6,600
﹤0.01% 529
2015
Q1
$432K Sell
6,600
-300
-4% -$19.9K ﹤0.01% 489
2014
Q4
$449K Sell
6,900
-900
-12% -$58K ﹤0.01% 446
2014
Q3
$469K Sell
7,800
-170,700
-96% -$11.2M ﹤0.01% 424
2014
Q2
$12.4M Buy
178,500
+74,300
+71% +$4.82M 0.09% 83
2014
Q1
$6.81M Buy
104,200
+96,300
+1,219% +$6.27M 0.05% 127
2013
Q4
$489K Sell
7,900
-1,000
-11% -$57.9K ﹤0.01% 386
2013
Q3
$477K Hold
8,900
﹤0.01% 391
2013
Q2
$406K Buy
+8,900
New +$386K ﹤0.01% 466

Other funds holding STJ

Daiwa Securities Group's STJ Position: Q1 2017 in Review

Daiwa Securities Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 7,450 shares — an estimated $597K sold.

Daiwa Securities Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $12.4M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Daiwa Securities Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Daiwa Securities Group sold 7,450 St Jude Medical shares in Q1 2017, an estimated $597K.
  • Daiwa Securities Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Daiwa Securities Group's St Jude Medical position peaked at $12.4M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Daiwa Securities Group's 13F filing for Q1 2017, filed 2 May 2017.